barr 250mg 589 (Didanosine 250 mg)

Pill imprint barr 250mg 589 has been identified as Didanosine 250 mg.

Didanosine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for barr 250mg 589

Didanosine 250 mg barr 250mg 589
Didanosine
Imprint:
barr 250mg
589
Strength:
250 mg
Color:
Blue & White
Size:
23.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00555-0589
Inactive Ingredients:
ferrosoferric oxide
croscarmellose sodium
D&C Yellow No. 10
aluminum oxide
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
gelatin
hydroxypropyl cellulose
hypromelloses
methacrylic acid
microcrystalline cellulose
polydextrose
polyethylene glycol
propylene glycol
shellac
silicon dioxide
sodium hydroxide
magnesium silicate
titanium dioxide
triacetin
triethyl citrate
D&C Red No. 28
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
62584-0046 Amerisource Health Services
68084-0431 Amerisource Health Services
13411-0192 Advanced Pharmaceutical Services Inc (repackager)
54868-5464 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)